· #COVID19 linked to a significant increase in dementia in older people with type 2 diabetes
[https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2026.1927383/full]
· Monoclonal antibody AER002 failed in a trial for #LongCOVID
[https://www.nature.com/articles/s41467-026-77925-y]
· FDA cleared a new phase 2 clinical trial for Long COVID studying an investigational botanical drug called FRP-003
[https://www.businesswire.com/news/home/20261006387219/en/Front-Range-Pharmaceuticals-Announces-FDA-Clearance-to-Initiate-Phase-2-Trial-of-FRP-003-in-Long-COVID]
https://thesicktimes.org/2026/10/13/research-updates-october-13/